欢迎来到CSNpharm!产品仅用于科研!

400-920-2911 sales@csnpharm.cn

0

您的位置 : 首页  /  Protein Tyrosine Kinase/RTK  /  FGFR  /  PRN1371

CAS No.: 1802929-43-6

PRN1371 Catalog No. CSN20388

PRN1371 is an irreversible covalent FGFR inhibitor used for the treatment of solid tumor.

规格 价格 促销价格 库存 数量
纯度 & 质量文件 批次:

靶点选择性

生物活性

  • 描述
  • 临床研究
  • NCT号适应症或疾病临床期招募状态预计完成时间地点
    NCT02608125Solid Tumors, Metastatic Bladd... more >>er Cancer Collapse <<Phase 1Active, not recruitingDecember 2019United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Cener San Francisco, California, United States, 94115 United States, Maryland Johns Hopkins Medicine Baltimore, Maryland, United States, 21205 United States, North Carolina Wake Forest University Health Sciences Medical Center Winston-Salem, North Carolina, United States, 27157 United States, Tennessee Sarah Canon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Spain Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Barcelona, Spain, 08035 START Madrid-FJD Fundacion Jiminez Diaz Madrid, Spain, 28040 START Madrid-CIOCC, Centro Integral Oncológico Clara Campal Madrid, Spain, 28050 Collapse <<

实验方案

技术信息

CAS号 1802929-43-6 储存条件
分子式 C26H30Cl2N6O4 运输 蓝冰
分子量 561.46 别名

大规格询价

号为必填项

姓名: 邮箱: 手机号:
留言:
   提交
联系
我们